Integrates genomic, proteomic, and phenotypic data into one view of disease. Finds hidden signatures that conventional methods miss, uncovering therapeutic targets and biomarkers with true clinical relevance.
Transforms raw insights into therapeutic strategies. Prioritizes targets by druggability, patient stratification, and clinical feasibility, creating clear pathways from discovery to patient benefit.
Combines living zebrafish models with AI analysis to uncover mechanisms and treatment effects traditional methods overlook. Tracks behavior, morphology, and physiology in real time, exposing efficacy and safety that static models can’t reveal.